Department of Health and Human Services July 16, 2020 – Federal Register Recent Federal Regulation Documents
Results 1 - 10 of 10
Privacy Act of 1974; System of Records
In accordance with the requirements of the Privacy Act of 1974, as amended, the Department of Health and Human Services (HHS) is establishing a new system of records, 09-90-2002, ``COVID-19 Insights Collaboration Records.'' HHS will use the records in this system of records to create and maintain a new database to be used by HHS to understand, track, and respond to the novel coronavirus known as SARS- CoV-2 and the outbreak of COVID-19 (the disease caused by SARS-CoV-2) which the Secretary of Health and Human Services declared a public health emergency effective January 27, 2020, and the World Health Organization (WHO) declared a pandemic on March 11, 2020. Creating and maintaining the new database may include retrieving identifiable records about patients by the patients' personal identifiers in order to connect, combine, or de-duplicate records that are about the same individual; however, at this time, HHS does not plan to retrieve records by personal identifier when using the resulting database for research, analysis, or other public health activities.
Agency Information Collection Activities: Proposed Collection; Comment Request
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve proposed updates to the approved information collection project ``Safety Program in Perinatal Care (SPPC)-II Demonstration Project.''
Prospective Grant of an Exclusive Patent License: Gene Therapy for Treatment or Prevention of Niemann-Pick Disease Type C1, Subject to Existing Three Non-Exclusive Licenses
The National Human Genome Research Institute is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the United States, European and Canadian Applications listed in the SUPPLEMENTARY INFORMATION section of this notice to AveXis, Inc., located in Bannockburn, Illinois, USA.
Interagency Coordinating Committee on the Validation of Alternative Methods Biennial Progress Report: 2018-2019; Availability of Report
The National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) announces availability of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Biennial Progress Report: 2018-2019. This report, prepared in accordance with requirements of the ICCVAM Authorization Act of 2000, describes activities and accomplishments from January 2018 through December 2019.
Prospective Grant of an Exclusive Patent License: Gene Therapy for Ocular Disease
The National Eye Institute, the National Institute on Deafness and Other Communication Disorders, and the National Heart, Lung, and Blood Institute, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an exclusive patent license to VegaVect, Inc., a start-up company spun- off from the University of Pittsburgh Medical Center Enterprises and incorporated as a C corporation under the laws of the state of Delaware, to practice the inventions covered by the patent estate listed in the SUPPLEMENTARY INFORMATION section of this notice. This is a second notice intended to apprise the public of a change in prospective licensee of the subject intellectual property rights in the stated field of use from a first notice: Prospective Grant of An Exclusive Patent License: Gene Therapy for Ocular Disease, published in the Federal Register on November 26, 2019.
Request for Information on Federal Coordination To Promote Economic Mobility for All Americans
HHS is publishing this Request for Information (RFI) to seek public input on the development of a federal interagency Council on Economic Mobility (Council). HHS and the Council will analyze information collected in this RFI to gather feedback from our stakeholders to better inform the Council's priorities and how the Council can promote economic mobility, recovery, and resilience.
Agency Information Collection Activities; Proposed Collection; Comment Request; Alzheimer's and Dementia Program Data Reporting Tool (ADP-DRT) OMB #0985-0022
The Administration for Community Living (ACL) is announcing an opportunity for the public to comment on the proposed collection of information listed above. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish a notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the Proposed Revision and solicits comments on the information collection requirements related to Alzheimer's and Dementia Program Data Reporting Tool (ADP-DRT).
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
